Shanghai, China

Fanglong Yang

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Jiangsu, CN (2013)
  • Shanghai, CN (2012 - 2021)

Company Filing History:


Years Active: 2012-2025

where 'Filed Patents' based on already Granted Patents

20 patents (USPTO):

Title: Fanglong Yang: A Pioneer in Fused Imidazole Derivatives

Introduction

Fanglong Yang is an accomplished inventor based in Shanghai, China, with an impressive portfolio of 17 patents. His work has significantly contributed to advancements in pharmaceuticals, particularly in the area of diabetes treatment and prevention through innovative compounds.

Latest Patents

Among his latest patents, Fanglong Yang focuses on fused imidazole derivatives, including their preparation methods and medical uses. These derivatives, which are detailed in his patent disclosures, offer promising therapeutic potential as GLP-1 receptor agonists. This innovation aims at providing new pharmaceutical compositions for treating and preventing diabetes, showcasing Fanglong's commitment to addressing widespread health challenges.

Career Highlights

Fanglong has worked with notable companies, including Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His involvement in these leading organizations has positioned him as a key figure in the pharmaceutical industry, allowing him to blend research with practical applications in drug development.

Collaborations

Throughout his career, Fanglong has collaborated with esteemed colleagues such as Feng He and Weikang Tao. These partnerships have enhanced his research capabilities and fostered a collaborative environment that encourages innovation and the successful pursuit of complex medical solutions.

Conclusion

Fanglong Yang stands out as a figure of innovation in the field of medicine. With his extensive patent portfolio and groundbreaking work on fused imidazole derivatives, he continues to make significant strides in developing effective treatments for diabetes, contributing to the advancement of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…